Atlas Trials

Multi-antigen CMV-Modified Vaccinia Ankara Vaccine in Treating Pediatric Patients With Positive Cytomegalovirus Undergoing Donor Stem Cell Transplant

Clinical trial NCT03354728 · RECRUITING

Trial details

NCT number
NCT03354728
Sponsor
City of Hope Medical Center
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cytomegaloviral InfectionHematopoietic Cell Transplant Recipient
Start date
2018-05-11
Primary completion
2026-12-11
Enrollment
80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.